The Global Coronary Stents Industry is on a trajectory to attain a significant valuation of US$ 51.2 million by the year 2032, exhibiting a steady compound annual growth rate (CAGR) of 5.1% from 2022 to 2032. In 2022, the market is expected to hit an estimated value of US$ 33.36 million. The market’s growth is …
Category Archives: Healthcare Trends
Global Hypercalcemia Treatment Industry on the Rise, Set to Reach US$55.07 Billion by 2033 with 11.8% CAGR
The Global Hypercalcemia Treatment Industry is on a resolute trajectory, with a predicted valuation of US$ 18.07 billion by the close of 2023. An impressive Compound Annual Growth Rate (CAGR) of 11.8% underpins this forecast. This steady ascent indicates that the market could surge to an impressive US$ 55.07 billion by 2033. Key Market Trends …
A Detailed Outlook on the US$5.91 Billion Global Dental Imaging Equipment Industry by 2030, as Unveiled by FMI
A recent study conducted by Future Market Insights (FMI) has projected an impressive growth trajectory for the Global Dental Imaging Equipment Industry. Anticipated to leap from a valuation of US$ 3.21 billion in 2022, the market is expected to reach a staggering US$ 5.91 billion by 2030, showcasing a robust Compound Annual Growth Rate (CAGR) …
Anti-Aging Products Services and Devices Industry Set for a 5.5% CAGR Surge to Reach US$ 109.8 Billion by 2033
The global market for Anti-Aging Products, Services, And Devices is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of 5.5% expected between 2023 and 2033. In 2022, the market was estimated to be valued at approximately US$ 59 billion. Projections from Future Market Insights (FMI) indicate a substantial revenue surge, with …
Indian Hemostat Industry’s Strong 5.8% CAGR Forecast from 2016 to 2025 | FMI Study
In 2015, the Indian Hemostat Industry showcased an impressive valuation of US$ 54.1 million, marking a significant milestone in the healthcare sector. A new era of expansion is on the horizon, as it is projected to maintain a compound annual growth rate (CAGR) of 5.8% from 2016 to 2025. This remarkable growth is attributed to …
Global Electronic Medical Records (EMR) Industry Surges with a 6.2% CAGR to Reach US$32.3 Billion by 2033 | FMI Insights
The Global Electronic Medical Records (EMR) Industry is on a trajectory of remarkable growth, with a projected valuation of US$ 32.3 billion by the year 2033, up from US$ 17.6 billion in 2023. This surge reflects an impressive Compound Annual Growth Rate (CAGR) of 6.2% during the forecast period, underlining the escalating adoption of electronic …
Global Companion Animal Drugs Industry to Attain US$ 59.2 Billion by 2033 at 4.4% CAGR | FMI Analysis
The Global Companion Animal Drugs Industry is on a steadfast growth trajectory, projected to attain a remarkable 4.4% Compound Annual Growth Rate (CAGR), ultimately reaching a substantial market valuation of US$ 59.2 billion by the close of 2033, compared to the US$ 36.7 billion recorded in 2022. Companion animals, including beloved pets such as dogs, …
Hydrokinetic Fiber Dressings Market Surges Toward US$ 251.1 Million by 2032: Revolutionizing Wound Care | Future Market Insights,Inc.
The hydrokinetic fibre dressings market is expected to grow from an estimated US$ 164.2 million in 2022 to US$ 251.1 million by 2032. The market is expected to grow at a compound annual growth rate (CAGR) of 3.9% from 2022 to 2032, as opposed to 3.6% from 2017 to 2021, the historical period. Hydrokinetic Fiber …
Breast Cancer Drug Market Poised to Reach US$ 12,012.1 Million by 2033: Advancing the Fight Against Breast Cancer | Future Market Insights,Inc.
The breast cancer drugs market is expected to grow at a stagnant CAGR of 1.1% from 2022 to 2032, when it is valued at US$ 11,750.33 million. In 2022, the target market is anticipated to be valued US$ 10,637.42 million. The market for breast cancer drugs is expected to grow during the forecast period as …
Blood Cancer Treatment Market Envisioned at US$ 15,735.3 Million by 2033: Pioneering Advances in Oncology | Future Market Insights,Inc.
The demand for blood cancer treatments market (leukaemia, non-Hodgkin lymphoma, hodgkin lymphoma, multiple myeloma) worldwide is anticipated to reach US$ 5,489.3 million in 2022 and US$ 12,943.6 million (US$ 10.2% CAGR) in 2032. With the latest insights and statistics from the biggest pharmaceutical and healthcare device manufacturers across the globe, FMI presents an extensive analysis …